Unprotected left main angioplasty in nonagenarians: Clinical characteristics, procedural features and outcome: A case series study

Journal of Invasive Cardiology

Volumn 22, Issue 5, 2010, Pages 231-234

  Rekik, Sofiene ^a   Brunet, Jérôme ^a   Bayet, Gilles ^a   Hager, Franois Xavier ^a   Meille, Laurent ^a   Quatre, Jean Michel ^a   Sainsous, Joël ^a  

^a Rhône Durance Clinic   (France)

Author keywords

angioplasty; nonagenarians; outcome; PCI; ULMCA; unprotected left main

Indexed keywords

ANTITHROMBOCYTIC AGENT; PACLITAXEL; METAL;

AGED; ANGIOPLASTY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; ELDERLY CARE; FEMALE; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; SCORING SYSTEM; STENT THROMBOSIS; SURGICAL PATIENT; SURGICAL RISK; THROMBECTOMY; TREATMENT OUTCOME; ANGIOCARDIOGRAPHY; CORONARY ARTERY DISEASE; RADIOGRAPHY; RISK FACTOR; STATISTICS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; METALS; RISK FACTORS; STENTS; TREATMENT OUTCOME;

EID: 77955901135     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Patel MR, Dehmer GJ, Hirshfeld JW, et al. JAACC/SCAI/STS/AATS/AHA/ASNC 2009 appropriateness criteria for coronary revascularization. J Am Coll Cardiol 2009;53:530-553.
2. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol. 2008 Jan 15;51:172-209.
3. Sillano D, Moretti C, Biondi-Zoccai G, Sheiban I. Percutaneous unprotected left main angioplasty with drug-eluting stents in a nonagenarian: Feasible and safe despite recurrent restenosis. Minerva Cardioangiol 2008;56:167-170.
4. Medina A, Suarez de Lezo J, Pan M. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006;59:183-184.
5. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic euroSCORE. Eur Heart J 2003;24:881-882.
6. Cutlip DE, Windecker S, Mehran R, et al. Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351.
7. Rodés-Cabau J, Deblois J, Bertrand OF, et al. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation 2008;118:2374-2381.
8. Palmerini T, Barlocco F, Santarelli A, et al. A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or = 75 years). Eur Heart J 2007;28:2714-2719.
9. Vaquerizo B, Lefèvre T, Darremont O, et al. Unprotected left main stenting in the real world: two-year outcomes of the French left main Taxus registry. Circulation 2009;119:2349-2356.
10. Seung KB, Park DW, Kim YH, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008;358:1781-1792.
11. Chieffo A, Park SJ, Valgimigli M, et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: A multicenter registry. Circulation 2007;116:158-162.
12. Gummert JF, Funkat A, Osswald B, et al. EuroSCORE overestimates the risk of cardiac surgery: Results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol 2009;98:363-369.
13. Mehilli J, Kastrati A, Byrne RA, et al. LEFT-MAIN intracoronary stenting and angiographic results: Drug-eluting stents for unprotected coronary left main lesions study Investigators. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol 2009;53:1760-1768.